More Stories

Informist, Monday, Jun. 30, 2025

 

--Apollo Hospitals board OKs demerging pharmacy, digital health platform ops

 

NEW DELHI – The board of Apollo Hospitals Enterprise Ltd. Monday approved a scheme of arrangement that will demerge its omni channel pharmacy business and the digital healthcare platform business and enable their direct listing. The company said in a stock exchange filing this will take place through a scheme of arrangement among the company, material subsidiary Apollo Healthco Ltd., Keimed Pvt. Ltd., and the resultant demerged company Apollo Healthtech Ltd.

 

The hospital company said no cash consideration will be discharged under the scheme. Equity shareholders of Apollo Hospitals will receive 195.2 shares of Apollo Healthtech for every 100 shares held by them. Apollo Healthtech is currently a wholly owned subsidiary of Apollo Hospitals and as per the scheme of arrangement, it will seek listing of its equity shares on the stock exchanges.

 

The combined turnover of the pharmacy and digital healthcare platform businesses was INR 701 million in 2024-25 (Apr-Mar), representing 0.86% of the total standalone turnover of the company, Apollo Hospitals said in its filing.

 

Under the scheme of arrangement, the company's material subsidiary Apollo Healthco, which is into wholesale trading of pharmaceutical and other products and operation of Apollo 24/7 digital platform, will get dissolved and demerged into Apollo Healthtech. Apollo Hospitals currently holds 78.88% stake in Apollo Healthco. It and other shareholders will receive 89.5 shares of Apollo Healthtech for every 100 shares held by them.

 

As per the scheme, the shareholders of wholesale pharmaceutical distributor Keimed, which is not a subsidiary or associate of Apollo Hospitals, will receive 3,045.2 shares of Apollo Healthtech for every 100 shares held by them. Keimed will be dissolved and merged into Apollo Healthtech.

 

Apollo Hospitals said in a press release it will seek to get the demerged company Apollo Healthtech in 18-21 months. The company said it will retain 15% in the demerged company and have one nominee director on its board.

 

The scheme will be subject to approvals from the Securities and Exchange Board of India, stock exchanges, National Company Law Tribunal, Competition Commission of India, and other statutory bodies, according to the company.

 

Monday, shares of Apollo Hospitals ended 0.9% lower at INR 7,242 on the National Stock Exchange.  End

 

Reported by Rajesh Gajra

Edited by Akul Nishant Akhoury

 

For users of real-time market data terminals, Informist news is available exclusively on the NSE Cogencis WorkStation.

 

Cogencis news is now Informist news. This follows the acquisition of Cogencis Information Services Ltd by NSE Data & Analytics Ltd, a 100% subsidiary of the National Stock Exchange of India Ltd. As a part of the transaction, the news department of Cogencis has been sold to Informist Media Pvt Ltd.

 

Informist Media Tel +91 (11) 4220-1000

Send comments to feedback@informistmedia.com

 

© Informist Media Pvt. Ltd. 2025. All rights reserved.